Type Ii Collagen Disorders Overview
Summary
The purpose of this overview is to increase the awareness of clinicians regarding type II collagen disorders and their management.
The following are the goals of this overview.
Goal 1.
Describe the clinical characteristics of type II collagen disorders.
Goal 2.
Provide an evaluation strategy to identify the genetic cause of a type II collagen disorder in a proband.
Goal 3.
Inform genetic counseling of family members of an individual with a type II collagen disorder.
Goal 4.
Review management of type II collagen disorders.
Diagnosis
Clinical Characteristics
Differential Diagnosis
The differential diagnosis of type II collagen disorders includes a range of disorders from severe, often lethal skeletal dysplasia with abnormal ossification and major skeletal abnormalities, to milder conditions with limited clinical and radiographic findings. Disorders with a known genetic etiology are listed (from most to least severe) in Table 2a; disorders of unknown or multifactorial etiology are listed in Table 2b.
Table 2a.
Type II Collagen Disorder | Differential Diagnosis Disorder | Gene(s) | MOI | Clinical Features of Differential Diagnosis Disorder | |
---|---|---|---|---|---|
Overlapping w/type II collagen disorders | Distinguishing from type II collagen disorders | ||||
Most severe 1 – achondrogenesis type II; hypochondrogenesis; platyspondylic dysplasia, Torrance type | Severe OI (see COL1A1/2-OI) | COL1A1 COL1A2 CRTAP P3H1 (LEPRE1) PPIB | AD AR |
|
|
Hypophosphatasia | ALPL | AD AR | Poor/delayed ossification |
| |
Achondrogenesis type 1A (OMIM 200600) | TRIP11 | AR |
|
| |
Achondrogenesis type 1B | SLC26A2 | AR |
|
| |
Atelosteogenesis type 2 | SLC26A2 | AR |
|
| |
Diastrophic dysplasia | SLC26A2 | AR |
| Hitchhiker thumbs/toes | |
Dyssegmental dysplasia, Silverman-Handmaker type (OMIM 224410) (may include Rolland-Desbuquois type) | HSPG2 | AR |
|
| |
Severe to moderately severe – Kniest dysplasia; SEDC; SEMD, Strudwick type | Metatropic dysplasia (see TRPV4-Associated Disorders | TRPV4 | AD |
|
|
Intermediate severity – spondyloperipheral dysplasia; SED w/metatarsal shortening (Czech dysplasia); 3 Stickler syndrome type 1 | MED, AD | COL9A1 COL9A2 COL9A3 COMP MATN3 | AD | Presents in early childhood, usually w/pain in hips &/or knees |
|
MED, recessive | SLC26A2 | AR |
|
| |
Progressive pseudorheumatoid dysplasia (SED w/progressive arthropathy) | CCN6 | AR |
|
| |
Stickler syndrome types 2, 3, 4, & 5 | COL11A1 COL11A2 COL9A1 COL9A2 COL9A3 | AD AR |
|
|
AD = autosomal dominant; ALP = alkaline phosphatase test; AR = autosomal recessive; OI = osteogenesis imperfecta; MED = multiple epiphyseal dysplasia; MOI = mode of inheritance; SED = spondyloepiphyseal dysplasia; SEDC = spondyloepiphyseal dysplasia congenita; SEMD = spondyloepimetaphyseal dysplasia
- 1.
Can be very difficult to distinguish antenatally
- 2.
Comprising characteristic type II collagen ocular, auditory, and orofacial abnormalities (i.e., high myopia, retinal detachment, hearing impairment, Pierre Robin sequence)
- 3.
Shortening of the third and/or fourth toes is a classic distinguishing hallmark of SED with metatarsal shortening (Czech dysplasia).
Table 2b.
Type II Collagen Disorder | Differential Diagnosis Disorder | Clinical Features of Differential Diagnosis Disorder | |
---|---|---|---|
Overlapping w/type II collagen disorders | Distinguishing from type II collagen disorders | ||
Intermediate severity – spondyloperipheral dysplasia; SED w/metatarsal shortening (Czech dysplasia) 1; Stickler syndrome type 1 | Juvenile idiopathic arthritis | Presents in childhood, usually w/joint pain | No facial, ophthalmic, or auditory abnormalities 3 |
Calve-Legg Perthes 2 | Presents in childhood, usually w/hip pain |
| |
Mild severity – mild SED w/premature arthrosis | Rheumatoid arthritis |
| More pronounced clinical & laboratory signs of inflammation |
Juvenile idiopathic arthritis | Joint pain |
|
AD = autosomal dominant; ALP = alkaline phosphatase test; AR = autosomal recessive; MED = multiple epiphyseal dysplasia; MOI = mode of inheritance; OI = osteogenesis imperfecta; SED = spondyloepiphyseal dysplasia; SEDC = spondyloepiphyseal dysplasia congenita; SEMD = spondyloepimetaphyseal dysplasia
- 1.
Shortening of the third and/or fourth toes is a classic distinguishing hallmark of spondyloepiphyseal dysplasia (SED) with metatarsal shortening (Czech dysplasia).
- 2.
COL2A1 pathogenic variants have been associated with a Calve-Legg-Perthes-like phenotype (more accurately dysplastic proximal femoral epiphyses). Bilateral hip involvement, especially symmetrical and synchronous, is suggestive of a type II collagen disorder. Bilateral involvement of femoral heads (including different stages of severity) warrant further attention and workup in general.
- 3.
Comprising characteristic type II collagen ocular, auditory, and orofacial abnormalities (i.e., high myopia, retinal detachment, hearing impairment, PRS)
Management
Evaluations Following Initial Diagnosis
To establish the extent of disease and needs in an individual diagnosed with type II collagen disorders, the evaluations summarized in Table 3 (if not performed as part of the evaluation that led to the diagnosis) are recommended:
Table 3.
System/Concern | Evaluation | Comment |
---|---|---|
Skeleton | Complete radiographic survey if indicated |
|
Cervical spine |
| Evaluate for cervical instability & risk of spinal cord compression. |
Thoracolumbar spine | Clinical examination & radiographs where indicated | Evaluate for progressive scoliosis. |
Respiratory |
|
|
Eyes | Dilated eye examination | Preferably by an expert ophthalmologist familiar w/the ophthalmic complications (e.g., high myopia, vitreous changes, retinal detachment, early cataract, vision problems, blindness) |
ENT/Mouth |
| |
Feeding | Swallowing assessment | In individuals w/PRS |
Musculoskeletal |
| Functional testing / activities of daily living should be considered. |
Genetics | Consultation w/clinical geneticist &/or genetic counselor | |
Psychosocial issues |
| Issues related to (e.g.) short stature, dysmorphic facial features, poor eyesight &/or hearing impairment, pain |
Adapted from Savarirayan et al [2019]
PRS = Pierre Robin sequence
Treatment of Manifestations
Table 4.
Manifestation/ Concern | Treatment | Considerations/Other |
---|---|---|
Cervical spine instability w/spine compression | Surgical management for medullopathy (C1-C2 fixation) | Management by an expert familiar w/rare skeletal dysplasia & spine involvement |
Scoliosis | Surgery for severe, progressive scoliosis | In young children, progressive scoliosis can be treated non-surgically (e.g., brace). |
Respiratory insufficiency |
| |
Sleep apnea |
| In case of central sleep apnea due to unrecognized unstable cervical spine, referral for evaluation & management |
Cleft palate | Surgery | |
High myopia, vitroretinal complications, & early cataract |
|
|
Hearing impairment | Hearing aids &/or surgery if indicated | |
Joint problems (laxity, contractures, pain due to early-onset arthrosis) |
|
|
Lower-limb malalignment |
| |
Obesity | Referral to clinical nutritionist | Even if weight is normal, importance of avoiding obesity should be emphasized. |
Psychosocial problems |
|
Adapted from Savarirayan et al [2019]
CPAP = continuous positive airway pressure
Surveillance
Table 5.
System/ Concern | Evaluation | Frequency |
---|---|---|
General health | Physical examination | Annually or as indicated |
Cervical spine |
| Every 2-3 yrs in those w/severe type II collagen disorder & no instability |
Thoracolumbar spine |
| Every 6-12 mos, depending on severity |
Respiratory |
| On a regular basis in individuals w/severe type II collagen disorder or severe, progressive kyphoscoliosis |
Eyes | Dilated eye examination |
|
ENT/ Mouth |
| Every 6-12 mos depending on severity |